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Abstract 
Prognosis of oropharyngeal squamous cell carcinoma depends on early diagnosis, despite advanced surgical techni-
ques, the 5-year survival rate remains ~40-50%. Unfortunately, it is usually detected when it becomes symptomatic. 
This requires treatment which gives rise to a high rate of morbidity and mortality and, furthermore, early detection 
of oro-pharyngeal pre-malignant lesions is important to improve the survival rate and quality of life.
Since dysplasia and in situ carcinoma contain much more DNA and RNA than the normal surrounding epithelium, 
the use of in vivo staining, by means of toluidine blue dye, is based on the fact that it is an acidophilic dye that selec-
tively stains acidic tissue components such as DNA and RNA. Toluidine blue staining is considered to be sensitive 
in identifying early oro-pharyngeal premalignant and malignant lesions.
In the present study, the use of toluidine blue staining was taken into consideration to identify clinically doubtful 
oro-pharyngeal lesions and to compare toluidine blue stain and with the histological evaluation. 
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Introduction
Malignancies of the upper aero digestive tract are one 
of the common malignancies in the world (1). In India, 
for example, oral cancers constitute 40% of all cancers 
and rank as the most common cancer in men and third 
most common cancer in women (2,3). Tumors arising 
from the oral and oropharyngeal malignancies are usua-
lly well advanced at the time of diagnosis (1). Prognosis 
of oropharyngeal squamous cell carcinoma (oral cavity 
and pharynx) depends on early diagnosis, despite ad-
vanced surgical techniques and adjuvant treatment, the 
5-year survival rate remains ~ 40-50% (4). The disease is 
life threatening, with high morbidity resulting from late 
treatment. However, if it is diagnosed at an early stage, 
oral cancer is often curable and inexpensive to treat (1).
The clinical examination is one of the best modalities in 
suspecting the pathology but the biggest disadvantage in 
the diagnosis lies in deciding the site of biopsy in early 
lesions and sometimes whether or not a biopsy is requi-
red in these lesions. Early stages are difficult to detect 
as the lesion may not be palpable and colour changes 
are not very different from the colour of the surrounding 
mucosa. Thus identifying clinically suspicious/undetec-
table lesions has gained importance whereby diagnosis 
can be confirmed by biopsy at an earlier stage (1).
In developing countries such as India, where there is 
high prevalence of disease, the focus is on down staging 
oral cancer at diagnosis from advanced to earlier dis-
ease. It is assumed that if premalignant lesion is detected 
and treated, the lesion may not progress to cancer (5).
In the past decades, adjunctive techniques have emerged 
with claims of enhancing the oral mucosal examinations 
and facilitating the detection of and distinctions between 
oral benign and oral premalignant and malignant lesions 
(5).
Techniques that are promoted or assessed to improve 
earlier detection and diagnosis of oral malignancy in-
clude toluidine blue, vizilite plus with touidine blue, 
velscope brush biopsy, etc. The gold standard diagnostic 
test for oral mucosal lesions that are suggestive of pre 
malignancy or malignancy remains tissue biopsy and 
histopathological examination.
Toluidine blue is a cationic metachromatic dye that may 
selectively bind to free anionic groups such as sulfate, 
phosphate, and carboxylate radicals of large molecules 
(6). It has been used for decades as an aid to the identi-
fication of mucosal abnormalities of the cervix as well 
as in the oral cavity. It has been valued by surgeons as 
a useful way of demarcating the extent of a lesion prior 
to excision (7). 
When evaluated as a part of the clinical examination, 
toluidine blue staining may provide additional informa-
tion. In vivo, toluidine blue stains deoxyribonucleic acid 
and/or may be retained in intracellular spaces of dysplas-
tic epithelium and clinically appear as royal blue areas 
(6). Toluidine blue staining is considered to be sensitive 
in identifying early oral premalignant and malignant le-
sions (4). Therefore, the aim of this study was to identify 
dysplastic changes undergoing in oral mucosal lesions 
with toluidine blue staining and to compare the results of 
toluidine blue stain with histopathological evaluation. 
Material and Methods
The study was focused on 40 oral mucosal lesions in 32 
patients, who reported to the Department of Oral Medi-
cine and Radiology, Maharishi Markandeshwar College 
of Dental Sciences and research, Mullana. Ethical ap-
proval was taken from the university ethical committee 
according to Declaration of Helsinki. Patients who clini-
cally presented with at least one oral mucosal lesion su-
spected of dysplastic changes and the patients who gave 
their consent for the study were included in the study. 
During history taking, information regarding habit of to-
bacco, its type, duration and frequency was recorded by 
asking the patient.  
Patient who had presence of frank malignancy or those 
who were suffering from any systemic disease that in-
terfere with or are contraindications to biopsy procedure 
or undergoing any dental treatment such as orthodontic 
appliances or prosthesis that may interfere with the ex-
amination, were excluded from the study.
All the lesions were first identified under visual ex-
amination. This was followed by an oral rinse with 1% 
acetic acid solution which was given to the patient to 
hold in the mouth for 20 seconds before expectorating. 
Toluidine blue (1% W/W) was applied as an oral rinse 
for 20 seconds and then 1% acetic acid was used for 20 
seconds to eliminate mechanically retained stain. Only 
the dark staining lesions were taken as positive whereas 
equivocal stains (faint stains) and the lesions which did 
not retain the stain at all were taken as negative but all 
the lesions were subjected to histopathological exami-
nation.
The biopsies were performed under local anaesthesia. 
The pathologists examining all the biopsies were not in-
formed regarding the clinical or staining evaluation of 
each sample. Histopathologic diagnoses were referred 
as: non-neoplastic (hyper-keratoses, hyper-para-kera-
toses, etc), mild dysplasia, moderate dysplasia, severe 
dysplasia, squamous cell carcinoma. For the statistical 
analysis, we used histopathologic assessment as the gold 
standard to which toluidine blue stains were compared.
Results
Out of 32 patients examined, 29 were males and 3 were 
females. Most common site where the lesion was pre-
sent was buccal mucosa in 57.5% of the total cases (23 
lesions) followed by labial vestibule 27.5% (11 lesions) 
and commissural area and buccal vestibule 7.5% each (3 
lesions) (Fig. 1). 
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conclusive reports, 14 (37.83%) were benign lesions 
(hyperkeratosis, hyperparakeratosis, epithelial and basi-
lar hyperplasia) and 23 were precancerous or cancerous 
lesions. Out of the 23 precancerous lesions, 13 (56.5%) 
were mild dysplasia and 10 (43.47%) were moderate 
dysplasia (Table 1).
Further it was observed that the most common habit 
amongst them was smoking tobacco which was seen 
in 17 patients (53%) followed by smokeless tobacco in 
7 patients (21%) and smoking and smokeless tobacco 
along with alcohol in 4 patients (13%)  (Fig. 2).
Fig. 1. Common site of occurrence of precancerous lesions.
Fig. 2. Distribution of habit amongst patients.
The results of toluidine blue staining showed that 29 
(72.5%) out of the total 40 oral mucosal lesions stained 
positive while 11 (27.5) were negative (Fig. 3). 
Histopathological examination of the 40 oral mucosal 
lesions showed 3 non-conclusive reports. Out of the 37 
Fig. 3. Results of toluidine blue staining.
Total lesions Benign lesions Precancerous lesion
37 14
23
13
Mild dysplasia
10
Moderate dysplasia
Table 1. Histopathological examination of conclusive reports.
The results of the toluidine blue staining and histolo-
gical findings are outlined in Table 2. When toluidine 
blue staining and histopathology were compared, it was 
observed that 10 (90.9%) out of the total 11 toluidine 
blue negative lesions were histologically benign lesions 
while 22 (84.6%) out of the 26 toluidine blue positive 
lesions were histologically defined as pre-cancerous or 
cancerous lesions.
The results of the toluidine blue test and histology, were 
compared in order to calculate the sensitivity (true-
positivity) and specificity (true-negatives) (Table 3). 
The sensitivity for toluidine blue staining was 95% and 
specificity was 71.45%. The positive predictive value 
for toluidine blue staining was 84.6% and the negative 
predictive value was 90.9% and the diagnostic accuracy 
was 86.48%.
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Discussion
The toluidine blue literature shows that it is a practical, 
rapid, inexpensive, and effective adjunct diagnostic tool 
(8). Toluidine blue, also known by its chemical name 
tolunium chloride, is a basic metachromatic dye that is 
known for its property of differentially staining mali-
gnant neoplasm but not normal epithelium. It is postula-
ted that the increased amount of DNA and RNA in neo-
plastic cells and the wider intercellular canals compared 
to normal epithelial cells are responsible for staining 
malignant cells (9). Its clinical application in staining 
neoplastic cells was first described by Richart in 1963 
(10) who used the dye to stain cervical carcinoma in situ. 
Since then it has emerged as a vital stain for detection of 
cervical dysplasia and carcinoma during colposcopy (9). 
More recently it has been recommended as an adjunctive 
method to assist in early detection of oral premalignant 
lesions and oral squamous cell carcinoma, to assist biop-
sy site selection, for assessment of margins of oral pre-
malignant lesions/ oral squamous cell carcinoma and in 
determining oral premalignant lesion at risk of progres-
sion to carcinoma (8).
In all fairness its ability to detect malignant oral cavi-
ty lesions has been well documented in clinical settings 
(8,9). Studies assessing Toluidine blue have shown a 
sensitivity and specificity ranging from 93.5 to 97.8% 
and 73.3 to 92.9% respectively (11).
Epstein et al. (12) while screening for recurrence in 
patients who had previously been treated for upper 
aero- digestive tract malignancies, found that the use of 
tolonium chloride rinse is more sensitive than clinical 
examination alone in detecting lesions that might be 
found on biopsy to be carcinoma or carcinoma in situ. 
They reported that the sensitivity increased with its use 
in detecting neoplasm as compared to unaided clinical 
exam from 26.6% to 96.7%. The increased sensitivity 
is largely attributed to lesions that stain but were not de-
tected clinically on visual examination (12). These fin-
dings were similar to those observed in our study where 
we found out sensitivity and specificity of toluidine blue 
staining in detecting premalignant/ malignant lesions 
was 95% and 71.4% respectively and the diagnostic 
accuracy of toluidine blue when compared with histo-
pathological evaluation came out to be 86.48%. Similar 
findings were observed by Allegra et al. (4) who con-
ducted a similar study on toluidine blue and reported a 
sensitivity of 96.2% and a specificity of 77.7%.  
The negative and the positive predictive value came out 
to be 90.9% and 84.6% respectively which was in accor-
dance with the study conducted by Allegra et al. (4). The-
refore, it was observed that toluidine blue might provide 
utility in reducing the number of biopsies by approxima-
tely half while identifying all lesions representing severe 
dysplasia and Oral Squamous Cell Carcinoma. 
The predictive values of a positive test for clinical exa-
mination and tolonium chloride staining were similar 
(36.4% vs 32.6%;  p = .5871), indicating that the greater 
sensitivity of tolonium chloride was not associated with 
an excessive number of unnecessary biopsies (false po-
sitives) (12). Therefore, toluidine blue negative lesions 
need not to be subjected to further histopathological exa-
mination, thus saving time and resources. 
Furthermore, it was observed that while comparing the 
dysplatic changes occurring at various sites with the 
histopathology, no statistically significant differences 
were observed (p=0.277), which depicted that it could 
not be used as a tool for site specific dysplastic chan-
ges. 
Toluidine blue is useful in raising or confirming clinical 
suspicion of malignancy or pre-malignancy and has the 
capability to reduce the number of biopsies being done. It 
has been proved in our study that when the lesion stained 
faintly, it came out to be histopathologically negative in 
most cases. Though our findings suggest that toluidine 
blue staining may be considered as an adjunctive diag-
nostic tool for detecting dysplastic changes in the epi-
thelium but larger studies are required to assertively and 
definitively answer the questions related to the screening 
use of toludine blue stains as early detection tool. 
Histology Toluidine blue negative (%) Toluidine blue positive (%)
Benign 10 (90.9) 4 (15.38)
Mild dysplasia 1 (9.09) 12 (46.15)
Moderate dysplasia 0(0) 10 (38.46)
Total 11 26
Table 2. Correlation between toluidine blue staining & histopathology.
Toluidine blue negative Toluidine blue positive 
Histopathologically negative 90.9% (10) 15.4% (1) 
Histopatologically positive 9.1%    (4) 84.6% (22) 
Table 3. Toluidine blue stain and histopathological correlation.
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